Welcome to the Australasian Lung cancer Trials Group
The Australasian Lung cancer Trials Group (ALTG) is Australia and New Zealand's lung and thoracic cancer clinical research group. The ALTG is a multi-disciplinary organization dedicated to reducing the incidence, morbidity and mortality of lung and other thoracic cancers and improving the quality of life of these patients, carers and families in Australia and New Zealand through the coordination and facilitation of high quality clinical research.
The ALTG collaborates with a number of organizations including the NHMRC Clinical Trials Centre (CTC) and Peter MacCallum Cancer Centre. Both of these groups are leaders in Australia for the design, conduct, analysis and publication of oncology clinical trials, including working with both Australia and international collaborative groups.
The specific objectives of the ALTG are:
- To facilitate participation in the development, conduct, evaluation, reporting of clinical trials in lung and thoracic cancer.
- To promote the use of clinical trials in evaluating new treatments and management approaches for lung and thoracic cancer.
- To contribute to the translation of clinical trial findings into clinical practice.
If you are interested in becoming a member of the ALTG please submit this form. Membership is complimentary to all medical and non-medical people interested in the conduct of trials in lung and thoracic cancer.
Last Updated (Thursday, 08 November 2012 09:10)